iCAD Reports Third Quarter 2017 Financial Results
Nov 08, 2017 21:01 pm UTC| Business
Total revenues increased 17% year-over-year; up 29% excluding MRI asset sale Conference Call today at 4:30 p.m. ET NASHUA, N.H., Nov. 08, 2017 -- iCAD, Inc. (NASDAQ:ICAD), an industry-leading provider of advanced...
AMAG Pharmaceuticals to Present at Upcoming Investor Conference
Nov 08, 2017 21:01 pm UTC| Business
WALTHAM, Mass., Nov. 08, 2017 -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that management will participate in the Jefferies 2017 London Healthcare Conference on Wednesday, November 15th at 2:40 p.m. GMT...
CymaBay Reports Third Quarter 2017 Financial Results and Corporate Updates
Nov 08, 2017 21:01 pm UTC| Business
NEWARK, Calif., Nov. 08, 2017 -- CymaBay Therapeutics, Inc. (NASDAQ:CBAY), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high unmet need, today...
Cidara Provides Corporate Update and Reports Third Quarter 2017 Financial Results
Nov 08, 2017 21:01 pm UTC| Business
SAN DIEGO, Nov. 08, 2017 -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today reported financial results for the three months ended...
TPI Expands its Strategic Relationship with Proterra to Manufacture Composite Bus Bodies
Nov 08, 2017 21:01 pm UTC| Business
SCOTTSDALE, Ariz., Nov. 08, 2017 -- TPI Composites, Inc., (TPI) (Nasdaq:TPIC), announced today that it has entered into a new, five-year supply agreement with Proterra Inc. to be the supplier of composite bus bodies for...
Cascadian Therapeutics Reports Third Quarter 2017 Financial Results
Nov 08, 2017 21:01 pm UTC| Business
SEATTLE, Nov. 08, 2017 -- Cascadian Therapeutics, Inc. (NASDAQ:CASC), a clinical-stage biopharmaceutical company, today reported financial results for the third quarter ended September 30, 2017, and provided an update...
Jay Nichols Joins National General Board of Directors
Nov 08, 2017 21:00 pm UTC| Business
NEW YORK, Nov. 08, 2017 -- National General Holdings Corp. (Nasdaq:NGHC) today announced the appointment of John “Jay” Nichols as an independent member of the Board of Directors, effective immediately. Mr. Nichols’s...
FDA Approval of Opdivo Injection Sparks Hope for Cancer Patients with Revolutionary Treatment Update